CobbleStone Software, the leader in contract management and eProcurement software, is exhibiting at NCMA's World Congress on July 28-31, 2019 at the Hynes Convention Center in Boston, MA. This annual event is considered one of the largest industry gatherings with thousands of contract management, procurement, and acquisition professionals expected to attend.
Maria Votlucka
Recent Posts
World Congress 2019: See CobbleStone's Adaptive & Connected Contract Management Suite
2 min read
General Counsel's Open-and-Shut Case for Better Contract Management
4 min read
Business continues to accelerate globally. The resulting rapidly shifting regulatory environment generates increased risk along with more opportunities, propelling organizations to rely on contracts more heavily to protect business interests and assets. General Counsel and legal teams have a chance to create a new perception of the legal department that moves away from the appearance of a cost center for the organization to the forefront of organizational strategy by leveraging contracts as a growth driver.
Engineer a Vendor Performance Management Process You Love
3 min read
When examining successful organizations, you’ll likely find that they have mastered vendor management. What does vendor management mastery look like? Effective vendor management drives value from contracts, nurtures long-term relationships, and is repeatable for organizations managing as many as thousands of different vendors. The strategy behind sound vendor management is to evaluate vendor performance over time, in core areas, including vendor reliability, vendor quality, vendor cost structures, and more granular areas based on your industry. This article addresses the critical need for better vendor management by outlining vendor performance management best practices.
Bio-Pharma Industry Transformation With Contract Management
2 min read
In early June, CobbleStone exhibited at BIO 2019 in Philadelphia, PA. There was an abundance of amazing keynotes, super sessions, fireside chats, receptions, and educational sessions ranging from “Biofuels & Renewable Chemicals” to “Value, Patient Access & Reimbursement.” The sessions on “Business Development & Finance,” “Emerging Opportunities in Global Markets,” and “Intellectual Property” made it clear that biotechnology and pharmaceutical industry leaders from life sciences and academic institutions are eager to face their challenges. Their strategy will beintegrating new technologies into their processes to improve operations, go-to-market efforts, R&D, profitability, and contract performance.
